Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.
about
Premutation in the Fragile X Mental Retardation 1 (FMR1) Gene Affects Maternal Zn-milk and Perinatal Brain Bioenergetics and Scaffolding.Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder.Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activationMass spectrometry as a tool for studying autism spectrum disorder.Shank3 Is Part of a Zinc-Sensitive Signaling System That Regulates Excitatory Synaptic Strength.The Relationship between Zinc Levels and Autism: A Systematic Review and Meta-analysis.DSM-5 ASD moves forward into the past.The plausibility of maternal toxicant exposure and nutritional status as contributing factors to the risk of autism spectrum disorders.Loss of COMMD1 and copper overload disrupt zinc homeostasis and influence an autism-associated pathway at glutamatergic synapses.Zinc deficiency dysregulates the synaptic ProSAP/Shank scaffold and might contribute to autism spectrum disorders.Neurotoxicity of Copper.Levels of metals in the blood and specific porphyrins in the urine in children with autism spectrum disorders.Prospects of Zinc Supplementation in Autism Spectrum Disorders and Shankopathies Such as Phelan McDermid Syndrome.
P2860
Q30008925-EB01CA4A-CDE0-42ED-9A14-36B9037B40D3Q30534798-B3624057-BD62-4BC0-ABA1-5C6AA1BA9AE2Q30655543-9B86D2C5-D284-4B08-9FD9-894C1CA67242Q34470350-E9F2ED18-DEFF-45CE-AA2A-1A452114D572Q37219065-5AA0CC5A-3A9D-48DC-8222-6D2CFC960F42Q37400404-C031556A-AE1A-422F-819B-877FED728943Q38117537-F37AACA7-13CB-43DF-B625-2AA304E8D35CQ40892251-44AAEA0D-51D2-43C0-AE92-902B04319BB9Q42704886-BD84A9CC-C28F-431C-82D0-1586F0F192C3Q45859857-8D97159C-3E60-4629-B7F4-C84C0859F02CQ48120135-B9DCE891-524E-432E-93E6-C9F6C2C804C1Q50304452-72F5DA9B-8280-432E-B4B6-67FABD05D447Q55111771-58ADB6CF-9667-46AF-988B-281458D14D14
P2860
Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@en
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@nl
type
label
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@en
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@nl
prefLabel
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@en
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@nl
P2860
P921
P356
P1433
P1476
Analysis of Copper and Zinc Pl ...... pecified (PDD-NOS) and Autism.
@en
P2093
Robert Devito
P2860
P304
P356
10.4137/BMI.S7286
P577
2011-11-08T00:00:00Z